RxSight (RXST) Current Assets (2020 - 2026)

RxSight's Current Assets history runs 7 years deep, the most recent figure standing at $279.2 million for Q1 2026.

• Quarterly Current Assets fell 3.19% year-over-year to $279.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $279.2 million (down 3.19% YoY) and the FY2025 annual result came in at $287.5 million, down 2.17% from the prior year.
• Current Assets was $279.2 million for Q1 2026 at RxSight, down from $287.5 million in the prior quarter.
• Across five years, Current Assets topped out at $293.8 million in Q4 2024 and bottomed at $134.6 million in Q4 2022.
• A 5-year average of $220.1 million and a median of $187.7 million in 2023 frame the typical range for Current Assets.
• Peak annual rise in Current Assets reached 98.46% in 2022, while the deepest fall reached 25.32% in 2022.
• RxSight's Current Assets stood at $134.6 million in 2022, then increased by 25.16% to $168.4 million in 2023, then soared by 74.47% to $293.8 million in 2024, then dropped by 2.17% to $287.5 million in 2025, then decreased by 2.86% to $279.2 million in 2026.
• Business Quant data shows RXST's Current Assets at $279.2 million in Q1 2026, $287.5 million in Q4 2025, and $283.9 million in Q3 2025.